
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Nodal CRISPR/Cas9 KO Plasmid (h) | sc-401439 | 20 µg | $397.00 |
NODAL encodes Nodal, a secreted TGF-β superfamily morphogen that signals primarily through Activin receptors and SMAD2/3 to regulate mesendoderm specification, left–right patterning, and maintenance of pluripotency programs during early development. In human cells, Nodal integrates with feedback regulators such as LEFTY and with crosstalk to WNT and FGF pathways to shape lineage decisions, epithelial–mesenchymal transitions, and transcriptional networks controlling stem cell states. Aberrant NODAL expression has been reported in multiple tumor contexts and is frequently studied for its association with invasive phenotypes, cellular plasticity, and resistance-associated signaling circuitry. As a pathway node, Nodal is commonly interrogated in developmental biology, cancer biology, and stem cell differentiation models.
Nodal CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the NODAL gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the NODAL together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the NODAL open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Nodal protein expression.
This CRISPR knockout system enables efficient generation of NODAL-deficient cell models for investigation of Nodal signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.